Search alternatives:
"c larger decrease" » "c marked decrease" (Expand Search), "c large decrease" (Expand Search), "_ large decrease" (Expand Search), "a large decrease" (Expand Search)
"_ larger decrease" » "_ marked decrease" (Expand Search), "_ large decrease" (Expand Search), "_ largest decrease" (Expand Search), "a large decrease" (Expand Search)
"_ cases increased" » "_ rate increased" (Expand Search), "_ levels increased" (Expand Search), "_ case increased" (Expand Search), "19 cases increased" (Expand Search)
Showing 1 - 20 results of 660 for search '(((("c larger decrease") OR ("_ larger decrease"))) OR ("_ cases increased"))', query time: 0.27s Refine Results
  1. 1
    A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity.

    A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

    Published 2020
    Save to List
    Saved in:
  2. 2
    Dramatic Lockdown Fossil Fuel CO<sub>2</sub> Decrease Detected by Citizen Science-Supported Atmospheric Radiocarbon Observations

    Dramatic Lockdown Fossil Fuel CO<sub>2</sub> Decrease Detected by Citizen Science-Supported Atmospheric Radiocarbon Observations by Jocelyn C. Turnbull (6083705)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 3
    Overview of fibrosis progression and metabolic comorbidities in patients +S and -S.

    Overview of fibrosis progression and metabolic comorbidities in patients +S and -S. by Monika Rau (826007)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 4
    Pulsed-pedestal task video demonstrates a trial in the pulsed-pedestal paradigm.

    Pulsed-pedestal task video demonstrates a trial in the pulsed-pedestal paradigm. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 5
    Change of serum liver enzymes from BL to FU1 for HCV patients with steatosis (+S) and without steatosis (-S) and without fibrosis progression.

    Change of serum liver enzymes from BL to FU1 for HCV patients with steatosis (+S) and without steatosis (-S) and without fibrosis progression. by Monika Rau (826007)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 6
    Baseline characteristics of HCV patients including all genotypes.

    Baseline characteristics of HCV patients including all genotypes. by Monika Rau (826007)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 7
    Rate of fibrosis progression over time in % for patients with steatosis (+S) at baseline and without steatosis (-S) at baseline.

    Rate of fibrosis progression over time in % for patients with steatosis (+S) at baseline and without steatosis (-S) at baseline. by Monika Rau (826007)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 8
    An observer’s steady- and pulsed-pedestal threshold data and model fits: (1) steady-pedestal paradigm (MC pathway) non-flicker adaptation condition (open circle); (2) steady-pedestal paradigm (MC pathway) flicker adaptation condition (filled circle); (3) pulsed-pedestal paradigm (PC pathway) non-flicker adaptation condition (open triangle); (4) pulsed-pedestal paradigm (PC pathway) flicker adaptation condition (filled triangle).

    An observer’s steady- and pulsed-pedestal threshold data and model fits: (1) steady-pedestal paradigm (MC pathway) non-flicker adaptation condition (open circle); (2) steady-pedest... by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 9
    Descriptive statistics for the free parameters.

    Descriptive statistics for the free parameters. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 10
    Fig 1 -

    Fig 1 - by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 11
    Steady-pedestal task video demonstrates a trial in the steady-pedestal paradigm.

    Steady-pedestal task video demonstrates a trial in the steady-pedestal paradigm. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  12. 12
    Baseline characteristics of HCV GT 1 and GT 3 patients.

    Baseline characteristics of HCV GT 1 and GT 3 patients. by Monika Rau (826007)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 13
    S1 Data -

    S1 Data - by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 14
    Metabolic features in HCV patients -S with and without fibrosis progression.

    Metabolic features in HCV patients -S with and without fibrosis progression. by Monika Rau (826007)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 15
    Fig 3 -

    Fig 3 - by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 16
    Averaged contrast sensitivity parameter data (Mean and SD) for the MC and PC pathways by age group.

    Averaged contrast sensitivity parameter data (Mean and SD) for the MC and PC pathways by age group. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 17
    Temporal Joinpoint Analysis of urolithiasis 20-54 Prevalence Rates, 1990-2021.

    Temporal Joinpoint Analysis of urolithiasis 20-54 Prevalence Rates, 1990-2021. by Weitao Yao (17523658)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    20-54 Structure of urolithiasis DALYs Rate among Males and Females, 2021.

    20-54 Structure of urolithiasis DALYs Rate among Males and Females, 2021. by Weitao Yao (17523658)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    20-54 Structure of urolithiasis Incidence Rate among Males and Females, 2021.

    20-54 Structure of urolithiasis Incidence Rate among Males and Females, 2021. by Weitao Yao (17523658)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    The prevalence of urinary stones and rates among 20-54years in 1990 and 2021, and the trends from 1990 to 2021.

    The prevalence of urinary stones and rates among 20-54years in 1990 and 2021, and the trends from 1990 to 2021. by Weitao Yao (17523658)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: